Namenda Only Works for Severe Alzheimer’s Disease and Dementia

Memantine, known by the brand name Namenda, was approved by the FDA in 2003 for use in people with “moderately severe to severe” Alzheimer’s disease. The FDA rejected the manufacturer’s application to expand approval to include moderate or mild Alzheimer’s. However, the drug is often prescribed “off-label” for patients with mild Alzheimer’s and mild cognitive impairment even though there is no evidence of its benefit. Continue reading